Use of MAC-ELISA for evaluation of yellow fever vaccination

Nogueira, Rita M. Ribeiro; Schatzmayr, Hermann G; Miagostovich, Marize P; Cavalcanti, Silvia M. B; Carvalho, Ricardo de.
Rev. Inst. Med. Trop. Säo Paulo ; 34(5): 447-50, set.-out. 1992. tab
Artículo en Inglés | LILACS | ID: lil-134544

Documentos relacionados

  1. Use of MAC-ELISA for evaluation of yellow fever vaccination.
  2. YF17D-based vaccines - standing on the shoulders of a giant.
  3. Vaccination reshapes the virus-specific T cell repertoire in unexposed adults.
  4. A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old.
  5. Even old foes can learn sweet new tricks.
  6. Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Final Report.
  7. Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine.
  8. Immunity and immune response, pathology and pathologic changes: progress and challenges in the immunopathology of yellow fever.
  9. Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination.
  10. What Controls the Acute Viral Infection Following Yellow Fever Vaccination?